Evaluasi Ketepatan Antipsikotik pada Pasien Skizofrenia di Instalasi Rawat Inap Rumah Sakit Jiwa Daerah Atma Husada Mahakam Samarinda

  • Khofifah Nurwahidah Balqis Laboratorium Penelitian dan Pengembangan Kefarmasian "Farmaka Tropis", Fakultas Farmasi, Universitas Mulawarman, Samarinda, Kalimantan Timur, Indonesia
  • Mukti Priastomo Laboratorium Penelitian dan Pengembangan Kefarmasian "Farmaka Tropis", Fakultas Farmasi, Universitas Mulawarman, Samarinda, Kalimantan Timur, Indonesia
  • Adam M. Ramadhan Laboratorium Penelitian dan Pengembangan Kefarmasian "Farmaka Tropis", Fakultas Farmasi, Universitas Mulawarman, Samarinda, Kalimantan Timur, Indonesia

Abstract

Schizophrenia is a psychotic mental disorder that causes psychiatric symptoms, such as confusion in thinking, emotions, perceptions, and deviant behavior. The purpose of this study was to determine the characteristics, pattern of use of antipsychotic drugs, and evaluation of the accuracy of antipsychotics for schizophrenia patients in the inpatient installation of RSJD Atma Husada Mahakam Samarinda including the right indication, the right patient, the right drug selection, the right dose, the right frequency and the right duration. administration based on Pharmacotherapy Handbook Tenth Edition Algorithms and Formularium schizophrenia at RSJD Atma Husada Mahakam Samarinda. This type of research is observational. The data collection was done retrospectively with the sampling technique with total sampling on medical records at RSJD Atma Husada Mahakam Samarinda. The results of The most prescribed antipsychotics in schizophrenia patients was the administration of a single antipsychotic risperidone (21.51%), and the administration of a clozapine-risperidone combination antipsychotic (20.43%). Accuracy of antipiscotic use with precise parameters of indication, patient, drug selection, dose, frequency of administration and exact duration of administration based on the Pharmacotherapy Handbook Tenth Edition Algorithms and formulary at RSJD Atma Husada Mahakam Samarinda is 100% accurate from the 93 drug prescriptions studied.

Author Biographies

Khofifah Nurwahidah Balqis, Laboratorium Penelitian dan Pengembangan Kefarmasian "Farmaka Tropis", Fakultas Farmasi, Universitas Mulawarman, Samarinda, Kalimantan Timur, Indonesia
Mukti Priastomo, Laboratorium Penelitian dan Pengembangan Kefarmasian "Farmaka Tropis", Fakultas Farmasi, Universitas Mulawarman, Samarinda, Kalimantan Timur, Indonesia
Adam M. Ramadhan, Laboratorium Penelitian dan Pengembangan Kefarmasian "Farmaka Tropis", Fakultas Farmasi, Universitas Mulawarman, Samarinda, Kalimantan Timur, Indonesia

References

[1] Fausiah, F, Windury. 2006. Psikologi Abnormal Klinis Dewasa. Universitas Indonesia: Indonesia.

[2] Pairan., Akhmad Munif Mubarok., Ekananda Novianta Nugraha. 2018. Metode Penyembuhan Penderita Skizofrenia Oleh Mantri Dalam Perspektif Pekerjaan Sosial. Jurnal Ilmu Kesejahteraan Sosial Vol. 7 No.1

[3] Zahnia, Siti. 2016. Kajian Epidemiologis Skizofrenia, Fakultas Kedokteran Universitas Lampung: Lampung.

[4] Irwan, M., Angga Fajriansyah., Besly Sinuhadji. Penatalaksanaan Skizofrenia, Falkutas Kedokteran Universitas Riau: Riau.

[5] Hariyanto, Rizka A, Putri., Eka K Untar. 2016. Perbedaan Jenis Terapi Antipsikotik terhadap Lama Rawat Inap Pasien Skizofrenia Fase Akut di RSJD Sungai Bangkong Pontianak. Jurnal Farmasi Klinik Indonesia Volume 5, Nomor 2

[6] [Kemenkes RI] Kementerian Kesehatan RI. 2011. Modul Penggunaan Obat Rasional. Indonesia

[7] Sona, Althof, Dita Hasni, Mutiara Anissa, Fredia Heppy. 2020. Identifikasi Keluhan Peningkatan Berat Badan Subjektif pada Pasien Skizofrenia yang Mendapat Terapi Antipsikotik di RSJ HB. Saanin Padang. Jurnal Kedokteran dan Kesehatan, Vol. 16, No. 1

[8] Rahaya, Anggie. 2016. Studi Retrospektif Penggunaan Trihexyfenidil Pada Pasien Skizofrenia Rawat Inap Yang Mendapat Terapi Antipskotik Di Rumah SakitJ iwa Sambang Lihum. Journal of Pharmacy Vol. 2 (2) : 124 ? 131

[9] Ikawati Z. 2014. Farmakoterapi Penyakit Sistem Saraf. Bursa Ilmu: Yogyakarta.

[10] Tan H.T. & Rahardja K. 2015. Obat-Obat Penting, Edisi 7. PT Elex Media Komputindo:Jakarta

[11] Hariyanto., Rizka A.. Putri., Eka K Untar. 2016. Perbedaan Jenis Terapi Antipsikotik terhadap Lama Rawat Inap Pasien Skizofrenia Fase Akut di RSJD Sungai Bangkong Pontianak. Jurnal Farmasi Klinik Indonesia Volume 5, Nomor 2

[12] Kirkpatrick B, et al., 2005. Comprehensive textbook of psychiatry 8th ed. Lippincott William & Wilkins: New York

[13] Addington D, Bouchard R.H, Goldberg J, et al, 2005. Clinical Practice Guidelines Treatment of schizophrenia. Journal Psychiatry. Vol. 13 No.1

[14] Dipiro, J.T, Wells, B.G, Schwinghammer, TL. 2017, Pharmacotherapy Handbook, Tenth Edition. McGraw-Hill Medical: New York

[15] Keputusan Direktur RSJD AHM] Rumah Sakit Jiwa Daerah Atma Husada Mahakam No. 188.4/48/RSJD-AHM/TU Tahun 2018 Tentang Formularium Obat dan Bahan Medis Habis Pakai Pada Rumah Sakit Jiwa Daerah Atma Husada Mahakam.

[16] Fahrul. 2014. Rasionalitas Penggunaan Antipsikotik Pada Pasien Skizofrenia Di Instalasi Rawat Inap Jiwa Rumah Sakit Daerah Madani Provinsi SulawesiTengah Periode Januari-April 2014. Jurnal of Natural Science, Vol.3(2): 18-29.
Published
2020-12-16
How to Cite
Balqis, K. N., Priastomo, M., & Ramadhan, A. M. (2020). Evaluasi Ketepatan Antipsikotik pada Pasien Skizofrenia di Instalasi Rawat Inap Rumah Sakit Jiwa Daerah Atma Husada Mahakam Samarinda. Proceeding of Mulawarman Pharmaceuticals Conferences, 12(1), 14-22. https://doi.org/10.25026/mpc.v12i1.403

Most read articles by the same author(s)